🚀 VC round data is live in beta, check it out!
RadNet Valuation Multiples
Discover revenue and EBITDA valuation multiples for RadNet and similar public comparables like PACS Group, Lantheus Holdings, Option Care Health, Ramsay Health and more.
RadNet Overview
About RadNet
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.
Founded
2008
HQ
Employees
11.0K
Website
Financials (LTM)
EV
$7B
RadNet Financials
RadNet reported last 12-month revenue of $2B and EBITDA of $314M.
In the same LTM period, RadNet generated $279M in gross profit, $314M in EBITDA, and $36M in net income.
Revenue (LTM)
RadNet P&L
In the most recent fiscal year, RadNet reported revenue of $2B and EBITDA of $314M.
RadNet expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Profit | $279M | XXX | $235M | XXX | XXX | XXX |
| Gross Margin | 13% | XXX | 12% | XXX | XXX | XXX |
| EBITDA | $314M | XXX | $314M | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| EBIT Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| Net Profit | $36M | XXX | ($19M) | XXX | XXX | XXX |
| Net Margin | 2% | XXX | (1%) | XXX | XXX | XXX |
| Net Debt | — | — | $323M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
RadNet Stock Performance
RadNet has current market cap of $6B, and enterprise value of $7B.
Market Cap Evolution
RadNet's stock price is $75.22.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7B | $6B | 35.5% | XXX | XXX | XXX | $-0.24 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRadNet Valuation Multiples
RadNet trades at 3.2x EV/Revenue multiple, and 21.9x EV/EBITDA.
EV / Revenue (LTM)
RadNet Financial Valuation Multiples
As of April 4, 2026, RadNet has market cap of $6B and EV of $7B.
Equity research analysts estimate RadNet's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
RadNet has a P/E ratio of 161.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV (current) | $7B | XXX | $7B | XXX | XXX | XXX |
| EV/Revenue | 3.2x | XXX | 3.4x | XXX | XXX | XXX |
| EV/EBITDA | 21.9x | XXX | 21.9x | XXX | XXX | XXX |
| EV/EBIT | 75.0x | XXX | 82.3x | XXX | XXX | XXX |
| EV/Gross Profit | 24.6x | XXX | 29.2x | XXX | XXX | XXX |
| P/E | 161.6x | XXX | (312.1x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 80.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified RadNet Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
RadNet Margins & Growth Rates
RadNet's revenue in the last 12 month grew by 18%.
RadNet's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
RadNet Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 18% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | 17% | XXX | (3%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 7% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
RadNet Public Comps
See public comps and valuation multiples for other Hospitals & Clinics and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| PACS Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Lantheus Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Option Care Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Bumrungrad Hospital | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
RadNet M&A Activity
RadNet acquired XXX companies to date.
Last acquisition by RadNet was on XXXXXXXX, XXXXX. RadNet acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by RadNet
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialRadNet Investment Activity
RadNet invested in XXX companies to date.
RadNet made its latest investment on XXXXXXXX, XXXXX. RadNet invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by RadNet
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout RadNet
| When was RadNet founded? | RadNet was founded in 2008. |
| Where is RadNet headquartered? | RadNet is headquartered in United States. |
| How many employees does RadNet have? | As of today, RadNet has over 11K employees. |
| Who is the CEO of RadNet? | RadNet's CEO is Norman R. Hames. |
| Is RadNet publicly listed? | Yes, RadNet is a public company listed on Nasdaq. |
| What is the stock symbol of RadNet? | RadNet trades under RDNT ticker. |
| When did RadNet go public? | RadNet went public in 1994. |
| Who are competitors of RadNet? | RadNet main competitors are PACS Group, Lantheus Holdings, Option Care Health, Ramsay Health. |
| What is the current market cap of RadNet? | RadNet's current market cap is $6B. |
| What is the current revenue of RadNet? | RadNet's last 12 months revenue is $2B. |
| What is the current revenue growth of RadNet? | RadNet revenue growth (NTM/LTM) is 18%. |
| What is the current EV/Revenue multiple of RadNet? | Current revenue multiple of RadNet is 3.2x. |
| Is RadNet profitable? | Yes, RadNet is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of RadNet? | RadNet's last 12 months EBITDA is $314M. |
| What is RadNet's EBITDA margin? | RadNet's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of RadNet? | Current EBITDA multiple of RadNet is 21.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.